Magnanimous Pharmaceuticals Private Limited

Founded in 2000 and headquartered in Chandigarh, India.

2000 | Chandigarh (India) | Merged
Last Updated: January 16, 2025

Magnanimous Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.25 Cr
  • Paid Up Capital ₹ 0.58 M
  • Company Age 24 Year, 6 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth 7.83%
  • Profit Growth 77.88%
  • Ebitda 63.74%
  • Net Worth -0.02%
  • Total Assets -3.46%

About Magnanimous Pharmaceuticals

Magnanimous Pharmaceuticals Private Limited (MPPL) is Amalgamated company established on 17 Jul 2000 with its office registered at Chandigarh, India and has been running since 24 Year, 6 Months with a paid up capital of 0.58 M. According to MCA records, 2 Directors are linked to this company as of 16 Jan 2025.

Company Details

  • Location

    Chandigarh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24117CH2000PTC023840

  • Company No.

    023840

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    17 Jul 2000

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chandigarh

Industry

Service

Who are the key members and board of directors at Magnanimous Pharmaceuticals?

Board Members (2)

Name Designation Appointment Date Status
Virender Dhawan Country flag representing In Director 01-Mar-2019 Current
Pankaj Jaswal Country flag representing In Director 24-Jun-2021 Current

Financial Performance of Magnanimous Pharmaceuticals.

Magnanimous Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 7.83% increase. The company also saw a substantial improvement in profitability, with a 77.88% increase in profit. The company's net worth dipped by a decrease of 0.02%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
7.83%
Revenue from Operations
Total Assets
-3.46%
Profit or Loss
77.88%
Net Worth
-0.02%
EBITDA
63.74%

What is the Ownership and Shareholding Structure of Magnanimous Pharmaceuticals?

In 2017, Magnanimous Pharmaceuticals had a promoter holding of 86.46% and a public holding of 13.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Magnanimous Pharmaceuticals?

Unlock and access historical data on people associated with Magnanimous Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Magnanimous Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnanimous Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Magnanimous Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Magnanimous Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Balance Sheet

    Magnanimous Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chandigarh.

    31 Mar 2022

  • Director Appointment

    Pankaj Jaswal was appointed as a Director was appointed as a Director on 24 Jun 2021 & has been associated with this company since 3 years 7 months .

    24 Jun 2021

  • Director Appointment

    Virender Kumar Dhawan was appointed as a Director was appointed as a Director on 01 Mar 2019 & has been associated with this company since 5 years 11 months .

    01 Mar 2019

  • Company Incorporation

    Magnanimous Pharmaceuticals Private Limited was registered on 17 Jul 2000 with Roc Chandigarh & aged 24 years 6 months as per MCA records.

    17 Jul 2000

Frequently asked questions

  • Magnanimous Pharmaceuticals Private Limited was incorporated on 17 Jul 2000.

  • The authorized share capital of Magnanimous Pharmaceuticals Private Limited is ₹ 1.25 Cr and paid-up capital is ₹ 0.58 M.

  • Currently 2 directors are associated with Magnanimous Pharmaceuticals Private Limited.

    • Virender Kumar Dhawan
    • Pankaj Jaswal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Magnanimous Pharmaceuticals Private Limited is Sco - 815 Top Floor Cabin No. 9 Shivalik Enclave Nac Manimajra, India, Chandigarh, 160101.

  • The corporate identification number (CIN) of Magnanimous Pharmaceuticals Private Limited is U24117CH2000PTC023840 and the company number is 023840 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Magnanimous Pharmaceuticals Private Limited has risen by 7.83%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Magnanimous Pharmaceuticals Private Limited has experienced an downturn of -0.02%.

  • The most recent Balance Sheet for Magnanimous Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Information Technology Services